- Filed
- Apr 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 14, 2025 | 481.27B sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 429.92B sh |
| Capex | FY 2024 · Dec 31, 2023 | $184.35K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$4.74M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $3.66M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $12.23M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $23.1M |
| Current Assets | FY 2024 · Dec 31, 2023 | $11.73M |
| Total Assets | FY 2024 · Dec 31, 2023 | $30.97M |
| Net Income | FY 2024 · Dec 31, 2023 | −$18.48M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$7.45M |
| Gross Profit restated | FY 2024 · Dec 31, 2023 | −$170 |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $787 |
| Revenue restated | FY 2024 · Dec 31, 2023 | $617 |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $20.21M |